IL197871A0
(en )
2009-12-24
Pharmaceutical solid dosage forms comprising compounds micro-embedded in ionic water-insoluble polymers
IL251539A0
(en )
2017-05-29
Unitary pharmaceutical dosage form
PL2399580T3
(en )
2013-12-31
Pharmaceutical dosage forms
IL185390A
(en )
2017-06-29
Solid pharmaceutical dosage formulation
IL211314A0
(en )
2011-04-28
Pharmaceutical dosage forms comprising poly (?รก-caprolactone)
HK1125295A1
(en )
2009-08-07
Microtablet-based pharmaceutical preparation
ZA200810164B
(en )
2009-11-25
Sustained release pharmaceutical dosage form containing phenylphrine
EP2112925A4
(en )
2013-01-09
Solid pharmaceutical dosage formulations
GB0803072D0
(en )
2008-03-26
Solid pharmaceutical and vaccien dose
ZA201005015B
(en )
2011-03-30
Solid pharmaceutical dosage form
EP1848749A4
(en )
2010-05-19
Contact drug delivery system
IL194007A0
(en )
2011-08-01
Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
SI3984528T1
(en )
2023-09-29
Pharmaceutical compositions comprising nilotinib
GB0614586D0
(en )
2006-08-30
Pharmaceutical Formulation
EP1862183A4
(en )
2009-12-30
Pharmaceutical composition containing hardly water soluble medicament
IL198780A0
(en )
2010-02-17
Pharmaceutical formulation comprising neurokinin antagonist
EP1948138A4
(en )
2012-07-11
Segmented pharmaceutical dosage forms
ZA200803152B
(en )
2009-06-24
Oramucosal pharmaceutical dosage form
ZA200808420B
(en )
2009-08-26
Pharmaceutical composition comprising anti-mirna anti-sense oligonucleotides
PL2002828T3
(en )
2019-11-29
Solid pharmaceutical preparation
IL195822A0
(en )
2009-09-01
Segmented pharmaceutical dosage forms
IL198160A0
(en )
2009-12-24
Pharmaceutical formulations
IL189827A0
(en )
2008-11-03
Pharmaceutical dosage forms and compositions comprising lecoztan
ZA200902498B
(en )
2010-03-31
Pharmaceutical solid dosage forms comprising compounds micro-embedded in ionic water-insoluble polymers
ZA200810270B
(en )
2009-12-30
Segmented pharmaceutical dosage forms